|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,119,756 |
|
|
Indirect Value
|
$12,961,771,173 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,043,890,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 43 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GHDX |
Genomic Health Inc |
Director |
|
2010-08-26 |
4 |
B |
$14.24 |
$571,161 |
I/I |
40,103 |
4,780,655 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-11-15 |
4 |
B |
$27.90 |
$1,126,869 |
I/I |
40,341 |
6,565,957 |
2.25 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2006-11-16 |
4 |
B |
$5.80 |
$236,010 |
I/I |
40,671 |
1,611,306 |
1.5 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2008-01-08 |
4 |
B |
$8.76 |
$356,538 |
I/I |
40,716 |
2,154,375 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-25 |
4 |
B |
$16.24 |
$680,782 |
I/I |
41,909 |
1,110,832 |
2.25 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2008-05-07 |
4 |
A |
$0.00 |
$0 |
I/I |
42,089 |
95,646 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-02-28 |
4 |
B |
$25.04 |
$1,058,018 |
I/I |
42,156 |
5,135,501 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2009-08-11 |
4 |
B |
$19.36 |
$832,907 |
I/I |
43,012 |
3,733,382 |
2.25 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-09 |
4 |
B |
$6.96 |
$299,449 |
I/I |
43,023 |
6,262,716 |
1.5 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2009-08-11 |
4 |
B |
$10.75 |
$463,691 |
I/I |
43,134 |
214,613 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-01 |
4 |
B |
$25.54 |
$1,104,574 |
I/I |
43,212 |
5,178,713 |
2.25 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2005-07-14 |
4 |
B |
$3.50 |
$151,554 |
I/I |
43,301 |
461,650 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2004-05-05 |
4 |
B |
$13.00 |
$564,148 |
I/I |
43,396 |
84,828 |
1.5 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2007-01-29 |
4 |
B |
$6.00 |
$263,724 |
I/I |
43,954 |
99,249 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-06-08 |
4 |
B |
$26.10 |
$1,164,432 |
I/I |
44,563 |
5,969,558 |
2.25 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-05-27 |
4 |
B |
$1.60 |
$71,640 |
I/I |
44,862 |
5,894,133 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-08-06 |
4 |
B |
$14.16 |
$636,250 |
I/I |
44,927 |
4,345,671 |
2.25 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2016-02-05 |
4 |
B |
$6.33 |
$284,657 |
I/I |
45,000 |
12,894,240 |
1.5 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2010-04-30 |
4/A |
B |
$12.76 |
$575,866 |
I/I |
45,112 |
344,949 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-08-30 |
4 |
B |
$14.44 |
$665,223 |
I/I |
46,047 |
4,864,263 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-14 |
4 |
B |
$8.06 |
$373,899 |
I/I |
46,306 |
3,933,090 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-11-22 |
4 |
B |
$26.03 |
$1,205,927 |
I/I |
46,328 |
6,716,525 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-21 |
4 |
B |
$27.98 |
$1,312,368 |
I/I |
46,909 |
7,639,436 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2007-04-17 |
4 |
S |
$15.43 |
$726,394 |
I/I |
(47,053) |
1,786,851 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-08-13 |
4 |
B |
$14.81 |
$703,529 |
I/I |
47,408 |
4,570,896 |
2.25 |
- |
|
1397 Records found
|
|
Page 43 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|